메뉴 건너뛰기




Volumn 2, Issue 1, 2010, Pages 233-240

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases

Author keywords

Antiplatelet therapy; Cardiovascular disease; Gastrointestinal; Proton pump inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PRASUGREL; PROTON PUMP INHIBITOR; THIENOPYRIDINE DERIVATIVE;

EID: 78650485004     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/DHPS.S7297     Document Type: Review
Times cited : (11)

References (50)
  • 1
    • 46049108934 scopus 로고    scopus 로고
    • Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed)
    • American College of Chest Physicians
    • Patrono C, Baigent C, Hirsh J, Roth G; American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed). Chest. 2008;133 Suppl 6:199S-233S.
    • (2008) Chest , vol.133 , Issue.SUPPL. 6
    • Patrono, C.1    Baigent, C.2    Hirsh, J.3    Roth, G.4
  • 2
    • 54049118496 scopus 로고    scopus 로고
    • ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
    • Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008;52(18):1502-1517.
    • (2008) J Am Coll Cardiol , vol.52 , Issue.18 , pp. 1502-1517
    • Bhatt, D.L.1    Scheiman, J.2    Abraham, N.S.3
  • 3
    • 0030013358 scopus 로고    scopus 로고
    • NSAIDs, gastrointestinal injury, and cytoprotection
    • Scheiman JM. NSAIDs, gastrointestinal injury, and cytoprotection. Gastroenterol Clin North Am. 1996;25(2):279-298.
    • (1996) Gastroenterol Clin North Am , vol.25 , Issue.2 , pp. 279-298
    • Scheiman, J.M.1
  • 4
    • 34548103823 scopus 로고    scopus 로고
    • Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: A meta-analysis of randomized trials
    • Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs. 2007;7(4):289-297.
    • (2007) Am J Cardiovasc Drugs , vol.7 , Issue.4 , pp. 289-297
    • Helton, T.J.1    Bavry, A.A.2    Kumbhani, D.J.3    Duggal, S.4    Roukoz, H.5    Bhatt, D.L.6
  • 5
    • 0033941958 scopus 로고    scopus 로고
    • Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators
    • Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators. Am Heart J. 2000;140(1):67-73.
    • (2000) Am Heart J , vol.140 , Issue.1 , pp. 67-73
    • Bhatt, D.L.1    Hirsch, A.T.2    Ringleb, P.A.3    Hacke, W.4    Topol, E.J.5
  • 6
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502.
    • (2001) N Engl J Med , vol.345 , Issue.7 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 7
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
    • Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331-337.
    • (2004) Lancet , vol.364 , Issue.9431 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass, L.M.3
  • 8
    • 33749681586 scopus 로고    scopus 로고
    • Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based case-control study
    • Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006;333(7571):726.
    • (2006) BMJ , vol.333 , Issue.7571 , pp. 726
    • Hallas, J.1    Dall, M.2    Andries, A.3
  • 9
    • 77953806506 scopus 로고    scopus 로고
    • Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    • Berger PB, Bhatt DL, Fuster V, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation. 2010;121(23):2575-2583.
    • (2010) Circulation , vol.121 , Issue.23 , pp. 2575-2583
    • Berger, P.B.1    Bhatt, D.L.2    Fuster, V.3
  • 10
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358(9281):527-533.
    • (2001) Lancet , vol.358 , Issue.9281 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 11
    • 70349456710 scopus 로고    scopus 로고
    • Gastrointestinal bleeding in high risk survivors of myocardial infarction: The VALIANT trial
    • Moukarbel GV, Signorovitch JE, Pfeffer MA, et al. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT trial. Eur Heart J. 2009;30(18):2226-2232.
    • (2009) Eur Heart J , vol.30 , Issue.18 , pp. 2226-2232
    • Moukarbel, G.V.1    Signorovitch, J.E.2    Pfeffer, M.A.3
  • 12
    • 65549120155 scopus 로고    scopus 로고
    • Management of patients with high gastrointestinal risk on antiplatelet therapy
    • Cryer B. Management of patients with high gastrointestinal risk on antiplatelet therapy. Gastroenterol Clin North Am. 2009;38(2):289-303.
    • (2009) Gastroenterol Clin North Am , vol.38 , Issue.2 , pp. 289-303
    • Cryer, B.1
  • 13
    • 33747599590 scopus 로고    scopus 로고
    • Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
    • Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114(8):774-782.
    • (2006) Circulation , vol.114 , Issue.8 , pp. 774-782
    • Eikelboom, J.W.1    Mehta, S.R.2    Anand, S.S.3    Xie, C.4    Fox, K.A.5    Yusuf, S.6
  • 14
    • 70349404215 scopus 로고    scopus 로고
    • Gastrointestinal bleeding in patients with acute coronary syndromes: Incidence, predictors, and clinical implications: Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    • Nikolsky E, Stone GW, Kirtane AJ, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009;54(14):1293-1302.
    • (2009) J Am Coll Cardiol , vol.54 , Issue.14 , pp. 1293-1302
    • Nikolsky, E.1    Stone, G.W.2    Kirtane, A.J.3
  • 15
    • 33847328353 scopus 로고    scopus 로고
    • Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants
    • Lanas A, García-Rodríguez LA, Arroyo MT, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol. 2007;102(3):507-515.
    • (2007) Am J Gastroenterol , vol.102 , Issue.3 , pp. 507-515
    • Lanas, A.1    García-Rodríguez, L.A.2    Arroyo, M.T.3
  • 16
    • 33745610044 scopus 로고    scopus 로고
    • Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications
    • Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 2006;4(7):860-865.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , Issue.7 , pp. 860-865
    • Lai, K.C.1    Chu, K.M.2    Hui, W.M.3
  • 17
    • 41849094074 scopus 로고    scopus 로고
    • Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome
    • Ng FH, Wong SY, Lam KF, et al. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome. Am J Gastroenterol. 2008;103(4):865-871.
    • (2008) Am J Gastroenterol , vol.103 , Issue.4 , pp. 865-871
    • Ng, F.H.1    Wong, S.Y.2    Lam, K.F.3
  • 18
    • 12144275353 scopus 로고    scopus 로고
    • Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
    • Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352(3):238-244.
    • (2005) N Engl J Med , vol.352 , Issue.3 , pp. 238-244
    • Chan, F.K.1    Ching, J.Y.2    Hung, L.C.3
  • 19
    • 72249105864 scopus 로고    scopus 로고
    • A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
    • Hsiao FY, Tsai YW, Huang WF, et al. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Clin Ther. 2009;31(9):2038-2047.
    • (2009) Clin Ther , vol.31 , Issue.9 , pp. 2038-2047
    • Hsiao, F.Y.1    Tsai, Y.W.2    Huang, W.F.3
  • 20
    • 78650681806 scopus 로고    scopus 로고
    • Accessed 2010 Apr 4
    • http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/Global_Top_15_Therapy_Classes.pdf. Accessed 2010 Apr 4.
  • 21
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411-2420.
    • (2002) JAMA , vol.288 , Issue.19 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann III, J.T.3
  • 22
    • 36148983750 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001-2015.
    • (2007) N Engl J Med , vol.357 , Issue.20 , pp. 2001-2015
    • Wiviott, S.D.1    Braunwald, E.2    McCabe, C.H.3
  • 23
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045-1057.
    • (2009) N Engl J Med , vol.361 , Issue.11 , pp. 1045-1057
    • Wallentin, L.1    Becker, R.C.2    Budaj, A.3
  • 24
    • 34547655744 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/
    • American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
    • Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1-e157.
    • (2007) J Am Coll Cardiol , vol.50 , Issue.7
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3
  • 25
    • 84872255603 scopus 로고    scopus 로고
    • US Food and Drug Administration, Available from
    • US Food and Drug Administration. Postmarket drug safety information for patients and providers. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/default.htm
    • Postmarket drug safety information for patients and providers
  • 27
    • 74849114254 scopus 로고    scopus 로고
    • International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding
    • Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152(2):101-113.
    • (2010) Ann Intern Med , vol.152 , Issue.2 , pp. 101-113
    • Barkun, A.N.1    Bardou, M.2    Kuipers, E.J.3
  • 28
    • 70450199115 scopus 로고    scopus 로고
    • 2009 focused updates: ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction
    • (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    • Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2009;54(23):2205-2241.
    • (2009) J Am Coll Cardiol , vol.54 , Issue.23 , pp. 2205-2241
    • Kushner, F.G.1    Hand, M.2    Smith Jr., S.C.3
  • 29
    • 70350332201 scopus 로고    scopus 로고
    • A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel
    • Hagihara K, Kazui M, Kurihara A, et al. A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel. Drug Metab Dispos. 2009;37(11):2145-2152.
    • (2009) Drug Metab Dispos , vol.37 , Issue.11 , pp. 2145-2152
    • Hagihara, K.1    Kazui, M.2    Kurihara, A.3
  • 30
    • 68149180722 scopus 로고    scopus 로고
    • Recent developments in clopidogrel pharmacology and their relation to clinical outcomes
    • Gurbel PA, Antonino MJ, Tantry US. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes. Expert Opin Drug Metab Toxicol. 2009;5(8):989-1004.
    • (2009) Expert Opin Drug Metab Toxicol , vol.5 , Issue.8 , pp. 989-1004
    • Gurbel, P.A.1    Antonino, M.J.2    Tantry, U.S.3
  • 31
    • 33748638016 scopus 로고    scopus 로고
    • Review article: The clinical pharmacology proton pump inhibitors
    • Sachs G, Shin JM, Howden CW. Review article: the clinical pharmacology proton pump inhibitors. Aliment Pharmacol Ther. 2006;23 Suppl 2:2-8.
    • (2006) Aliment Pharmacol Ther , vol.23 , Issue.SUPPL. 2 , pp. 2-8
    • Sachs, G.1    Shin, J.M.2    Howden, C.W.3
  • 33
    • 33750079553 scopus 로고    scopus 로고
    • Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
    • Gilard M, Arnaud B, le Gal G, Abgrall JF, Boschat J. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. J Thromb Haemost. 2006;4(11):2508-2509.
    • (2006) J Thromb Haemost , vol.4 , Issue.11 , pp. 2508-2509
    • Gilard, M.1    Arnaud, B.2    le Gal, G.3    Abgrall, J.F.4    Boschat, J.5
  • 34
    • 38349065084 scopus 로고    scopus 로고
    • Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study
    • Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51(3):256-260.
    • (2008) J Am Coll Cardiol , vol.51 , Issue.3 , pp. 256-260
    • Gilard, M.1    Arnaud, B.2    Cornily, J.C.3
  • 35
    • 40749094082 scopus 로고    scopus 로고
    • Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel
    • Small DS, Farid NA, Payne CD, et al. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol. 2008;48(4):475-484.
    • (2008) J Clin Pharmacol , vol.48 , Issue.4 , pp. 475-484
    • Small, D.S.1    Farid, N.A.2    Payne, C.D.3
  • 36
    • 70249139788 scopus 로고    scopus 로고
    • Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton pump inhibitor: An analysis of two randomized trials
    • O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton pump inhibitor: an analysis of two randomized trials. Lancet. 2009;374(9694):989-997.
    • (2009) Lancet , vol.374 , Issue.9694 , pp. 989-997
    • O'Donoghue, M.L.1    Braunwald, E.2    Antman, E.M.3
  • 37
    • 64849087438 scopus 로고    scopus 로고
    • Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel
    • Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost. 2009;101(4):714-719.
    • (2009) Thromb Haemost , vol.101 , Issue.4 , pp. 714-719
    • Sibbing, D.1    Morath, T.2    Stegherr, J.3
  • 38
    • 76449083482 scopus 로고    scopus 로고
    • Effect of comedication with proton pump inhibitors (PPIs) on postinterventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy
    • Zuern CS, Geisler T, Lutilsky N, Winter S, Schwab M, Gawaz M. Effect of comedication with proton pump inhibitors (PPIs) on postinterventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy. Thromb Res. 2010;125(2):e51-e54.
    • (2010) Thromb Res , vol.125 , Issue.2
    • Zuern, C.S.1    Geisler, T.2    Lutilsky, N.3    Winter, S.4    Schwab, M.5    Gawaz, M.6
  • 40
    • 70049098599 scopus 로고    scopus 로고
    • Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study
    • Cuisset T, Frere C, Quilici J, et al. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study. J Am Coll Cardiol. 2009;54(13):1149-1153.
    • (2009) J Am Coll Cardiol , vol.54 , Issue.13 , pp. 1149-1153
    • Cuisset, T.1    Frere, C.2    Quilici, J.3
  • 41
    • 51049115517 scopus 로고    scopus 로고
    • Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors [letter]
    • Pezalla E, Day D, Pulliadath I. Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors [letter]. J Am Coll Cardiol. 2008;52(12):1038-1039.
    • (2008) J Am Coll Cardiol , vol.52 , Issue.12 , pp. 1038-1039
    • Pezalla, E.1    Day, D.2    Pulliadath, I.3
  • 42
    • 77649187092 scopus 로고    scopus 로고
    • A national study of the effect of individual proton pump inhibitors on cardiovascular outcomes in patients treated with clopidogrel following coronary stenting: The clopidogrel Medco outcomes study
    • Presented at the, May 6-9; Las Vegas, Nevada
    • Stanek EJ, Aubert RE, Flockhart FA, et al. A national study of the effect of individual proton pump inhibitors on cardiovascular outcomes in patients treated with clopidogrel following coronary stenting: the clopidogrel Medco outcomes study. Presented at the Meeting of the Society of Cardiovascular Angiography and Interventions; 2009 May 6-9; Las Vegas, Nevada.
    • (2009) Meeting of the Society of Cardiovascular Angiography and Interventions
    • Stanek, E.J.1    Aubert, R.E.2    Flockhart, F.A.3
  • 43
    • 64849116567 scopus 로고    scopus 로고
    • Baseline proton pump inhibitor use is associated with increased cardiovascular events with and without the use of clopidogrel in the CREDO trial [abstract 3999]
    • Dunn SP, Macaulay TE, Brennan DM, et al. Baseline proton pump inhibitor use is associated with increased cardiovascular events with and without the use of clopidogrel in the CREDO trial [abstract 3999]. Circulation. 2008;118:S815.
    • (2008) Circulation , vol.118
    • Dunn, S.P.1    Macaulay, T.E.2    Brennan, D.M.3
  • 44
    • 62649164844 scopus 로고    scopus 로고
    • A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
    • Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):713-718.
    • (2009) CMAJ , vol.180 , Issue.7 , pp. 713-718
    • Juurlink, D.N.1    Gomes, T.2    Ko, D.T.3
  • 45
    • 61549124132 scopus 로고    scopus 로고
    • Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
    • Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301(9):937-944.
    • (2009) JAMA , vol.301 , Issue.9 , pp. 937-944
    • Ho, P.M.1    Maddox, T.M.2    Wang, L.3
  • 46
    • 77649208686 scopus 로고    scopus 로고
    • Clopidogrel and the optimization of GI events trial (COGENT)
    • Presented at the, Sep 21-25; San Francisco, California
    • Bhatt DL, Cryer B, Contant CF, et al. Clopidogrel and the optimization of GI events trial (COGENT). Presented at the Transcatheter Cardiovascular Therapeutics Meeting; 2009 Sep 21-25; San Francisco, California.
    • (2009) Transcatheter Cardiovascular Therapeutics Meeting
    • Bhatt, D.L.1    Cryer, B.2    Contant, C.F.3
  • 47
    • 73449122247 scopus 로고    scopus 로고
    • Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome
    • Rassen JA, Choudhry NK, Avorn J, Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009;120(23):2322-2329.
    • (2009) Circulation , vol.120 , Issue.23 , pp. 2322-2329
    • Rassen, J.A.1    Choudhry, N.K.2    Avorn, J.3    Schneeweiss, S.4
  • 48
    • 77949690349 scopus 로고    scopus 로고
    • Meta-analysis: The effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel
    • Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther. 2010;31(8):810-823.
    • (2010) Aliment Pharmacol Ther , vol.31 , Issue.8 , pp. 810-823
    • Kwok, C.S.1    Loke, Y.K.2
  • 49
    • 77951687662 scopus 로고    scopus 로고
    • Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor
    • Stockl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med. 2010;170(8):704-710.
    • (2010) Arch Intern Med , vol.170 , Issue.8 , pp. 704-710
    • Stockl, K.M.1    Le, L.2    Zakharyan, A.3
  • 50
    • 77950895115 scopus 로고    scopus 로고
    • Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: A cohort study
    • Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med. 2010;152(6):337-345.
    • (2010) Ann Intern Med , vol.152 , Issue.6 , pp. 337-345
    • Ray, W.A.1    Murray, K.T.2    Griffin, M.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.